Companies:
49,940
Total Market Cap:
142416685308702.53
Global Rank
#41753
Country Rank
#3289
Market Cap
8.19 M
Price
0.415
Change (%)
0.25%
Volume
31,066
Vivo Bio Tech Limited's latest marketcap:
8.19 M
As of 07/25/2025, Vivo Bio Tech Limited's market capitalization has reached $8.19 M. According to our data, Vivo Bio Tech Limited is the 41753th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8.19 M |
| Revenue (ttm) | 5.4 M |
| Net Income (ttm) | 842,162.47 |
| Shares Out | 20 M |
| EPS (ttm) | 0.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/09/2025 |
Market Cap Chart
Data Updated: 07/25/2025
Vivo Bio Tech Limited's yearly market capitalization.
Vivo Bio Tech Limited has seen its market value grow from ₹154.75 M to ₹708.4 M since 2014, representing a total increase of 357.76% and an annual compound growth rate (CAGR) of 15.47%.
| Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/25/2025 | ₹708.4 M | $8.19 M | 18.46% | 41753 |
| 12/31/2024 | ₹598.85 M | $7 M | 21.4% | 39580 |
| 12/29/2023 | ₹493.31 M | $5.93 M | 12.03% | 39104 |
| 12/30/2022 | ₹440.34 M | $5.32 M | -54.94% | 38117 |
| 12/31/2021 | ₹977.27 M | $13.11 M | 38.88% | 34585 |
| 12/31/2020 | ₹703.66 M | $9.63 M | 90.24% | 32256 |
| 12/31/2019 | ₹369.87 M | $5.18 M | -48.56% | 30648 |
| 12/31/2018 | ₹719.09 M | $10.33 M | 54.12% | 27756 |
| 12/29/2017 | ₹466.59 M | $7.31 M | -34.21% | 28366 |
| 12/29/2016 | ₹709.24 M | $10.43 M | 152.41% | 25206 |
Company Profile
About Vivo Bio Tech Limited
Vivo Bio Tech Limited is a global provider of drug development and discovery services, catering to pharmaceutical and biotech companies. Established in 1987 and headquartered in Hyderabad, India, the company was formerly known as Sunshine Factors & Exports Limited before rebranding in September 2002.
Core Services
- Preclinical Research: In vivo and in vitro toxicity studies, pharmacological investigations, and pharmacokinetic/toxicokinetic studies.
- Genotoxicity Screening: Comprehensive analytical services for molecule evaluation.
- Regulatory & Non-Regulatory Services: IND preclinical support for drug development.
- Model Development: Design and development of syngeneic/xenograft models for anti-cancer agent evaluation.
Additional Offerings
- Lab Animal Supply: Breeding and distribution of SPF lab animals and custom rodent models.
- Stem Cell Products: Specialized solutions for research and development.
- Lab Animal Diets: High-quality nutrition for research animals.
Frequently Asked Questions
-
What is Vivo Bio Tech Limited's (BOM-511509) current market cap?As of 07/25/2025, Vivo Bio Tech Limited (including the parent company, if applicable) has an estimated market capitalization of $8.19 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Vivo Bio Tech Limited (BOM-511509) rank globally by market cap?Vivo Bio Tech Limited global market capitalization ranking is approximately 41753 as of 07/25/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.